Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis-Reference-Cited by-同舟云学术

Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis

Published:2016-03-04 Issue:4 Volume:20 Page:589-600
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Mei Changlin¹,Chen Nan²,Ding Xiaoqiang³,Yu Xueqing⁴,Wang Li⁵,Qian Jiaqi⁶,Wang Mei⁷,Jiang Gengru⁸,Li Xuemei⁹,Hou Fanfan¹⁰,Zuo Li¹¹,Wang Niansong¹²,Liu Hong¹³

Affiliation:

1. Shanghai Changzheng Hospital; Shanghai China

2. Ruijin Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai China

3. Zhongshan Hospital Fudan University; Shanghai China

4. The First Affiliated Hospital, Sun Yat-sen University; Guangzhou China

5. Sichuan Provincial People's Hospital; Chengdu China

6. Renji Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai China

7. Peking University People's Hospital; Beijing China

8. Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai China

9. Peking Union Medical College Hospital; Beijing China

10. Nanfang Hospital; Guangzhou China

11. Peking University First Hospital; Beijing China

12. The Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai China

13. Kyowa Hakko Kirin China Pharmaceutical Co., Ltd; China

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hdi.12410/fullpdf

Reference29 articles.

1. The hyperparathyroidism of chronic renal failure: a disorder of growth;Parfitt;Kidney Int.,1997

2. Hyperparathyroidism and dialysis vintage;Chertow;Clin Nephrol.,2000

3. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study;Block;Am J Kidney Dis.,1998

4. Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race;Owda;Ren Fail.,2003

5. An update on vitamin D as related to nephrology practice: 2003;Coburn;Kidney Int.,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of active vitamin D analogs and calcimimetic agents on PTH and bone mineral biomarkers in hemodialysis patients with SHPT: a network meta-analysis;European Journal of Clinical Pharmacology;2024-07-13

2. Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta‐analysis of randomized studies;Therapeutic Apheresis and Dialysis;2024-03-18

3. Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism;Kidney International Reports;2023-11

4. A Systematic Review and Meta-analysis of Efficacy and Safety of Calcimimetic Agents in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease;Current Pharmaceutical Design;2022-11

5. A Phase I, Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Etelcalcetide Administered Intravenously to Chinese Patients With Chronic Kidney Disease Undergoing Hemodialysis;Clinical Therapeutics;2021-11